Intervention Review

Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia

  1. Karla Soares-Weiser1,*,
  2. John Rathbone2

Editorial Group: Cochrane Schizophrenia Group

Published Online: 25 JAN 2006

Assessed as up-to-date: 19 SEP 2005

DOI: 10.1002/14651858.CD000459.pub2

How to Cite

Soares-Weiser K, Rathbone J. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD000459. DOI: 10.1002/14651858.CD000459.pub2.

Author Information

  1. 1

    Enhance Reviews, Kfar-Saba, Israel

  2. 2

    University of Nottingham, Cochrane Schizophrenia Group, Nottingham, UK

*Karla Soares-Weiser, Enhance Reviews, PO Box 137, Kfar-Saba, 44101, Israel. ksoares@netvision.net.il. karla@enhance-reviews.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 25 JAN 2006

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Peter N. van Harten, Diederik E. Tenback, Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia, 2011,

    CrossRef

  2. 2
    Oscar S. Gershanik, Gonzalo J. Gómez Arévalo, Hyperkinetic Movement Disorders, 2011,

    CrossRef

  3. 3
    Kelvin L. Chou, Joseph H. Friedman, Tardive Syndromes in the Elderly, Clinics in Geriatric Medicine, 2006, 22, 4, 915

    CrossRef

  4. 4
    Adib Essali, Hany Deirawan, Karla Soares-Weiser, Clive E Adams, Calcium channel blockers for neuroleptic-induced tardive dyskinesia, The Cochrane Library,